| [1] |
Ando M. An overview of kidney disease following hematopoietic cell transplantation [J]. Intern Med, 2018, 57(11): 1503-1508.
|
| [2] |
Hu SL. The role of graft－versus－host disease in haematopoietic cell transplantation－associated glomerular disease [J]. Nephrol Dial Transplant, 2011, 26(6): 2025-2031.
|
| [3] |
Byrne－Dugan CJ, Collins AB, Lam AQ, et al. Membranous nephropathy as a manifestation of graft－versus－host disease: association with HLA antigen typing, phospholipase A2 receptor, and C4d [J]. Am J Kidney Dis, 2014, 64(6): 987-993.
|
| [4] |
Flanagan DM, Jennings CD, Goes SW, et al. Nitric oxide participates in the intestinal pathology associated with murine syngeneic graft－versus－host disease [J]. J Leukoc Biol, 2002, 72(4): 762-768.
|
| [5] |
Niscola P, Tendas A, Luo XD, et al. The management of membranous glomerulopathy in allogeneic stem cells transplantation: updated literature [J]. Cardiovasc Hematol Agents Med Chem, 2013, 11(1): 67-76.
|
| [6] |
McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature [J]. Nephrol Dial Transplant, 2011, 26(2): 414-430.
|
| [7] |
Hess AD, Thoburn CJ, Chen W, et al. Complexity of effector mechanisms in cyclosporine－induced syngeneic graft－versus－host disease [J]. Biol Blood Marrow Transplant, 2000, 6(1): 13-24.
|
| [8] |
Wardemann H, Yurasov S, Schaefer A, et al. Predominant autoantibody production by early human B cell precursors [J]. Science, 2003, 301(5638): 1374-1377.
|
| [9] |
Patriarca F, Skert C, Sperotto A, et al. The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft－vs－host disease and immune recovery [J]. Exp Hematol, 2006, 34(3): 389-396.
|
| [10] |
Brukamp K, Doyle AM, Bloom RD, et al. Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft－versus－host disease？[J]. Clin J Am Soc Nephrol, 2006, 1(4): 685-694.
|
| [11] |
Beyar Katz O, Davila EK, Zuckerman T, et al. Adult nephrotic syndrome after hematopoietic stem cell transplantation: renal pathology is the best predictor of response to therapy [J]. Biol Blood Marrow Transplant, 2016, 22(6): 975-981.
|
| [12] |
Huang X, Qin W, Zhang M, et al. Detection of anti－PLA2R autoantibodies and IgG subclasses in post－allogeneic hematopoietic stem cell transplantation membranous nephropathy [J]. Am J Med Sci, 2013, 346(1): 32-37.
|